Cable Car Capital’s Forte Biosciences FBRX Stock Holding History

Cable Car Capital’s Portfolio FBRX Stock Details FBRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10.4M	Hold	400,000	–	–	3.58%	5
2025 Q4	$10.9M	Sell	400,000 -100,000	-20%	-$1.75M	0.36%	19
2025 Q3	$7.5M	Hold	500,000	–	–	3.21%	5
2025 Q2	$6.46M	Buy	500,000 +280,396	+128%	+$2.41M	2.07%	6
2025 Q1	$1.7M	Hold	219,604	–	–	1.93%	20
2024 Q4	$4.99M	Buy	219,604 +138,325	+170%	+$1.65M	0.2%	42
2024 Q3	$454K	Hold	81,279	–	–	0.49%	38
2024 Q2	$1.09M	Hold	81,279	–	–	1.15%	24
2024 Q1	$1.41M	Hold	81,279	–	–	1.95%	19
2023 Q4	$1.67M	Buy	+81,279	New	+$1.14M	1.73%	17

Other funds holding FBRX

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Cable Car Capital's FBRX Position: Q1 2026 in Review

Cable Car Capital held its Forte Biosciences (FBRX) position steady in Q1 2026 at 400,000 shares worth $10.4M. The position accounts for 3.58% of the portfolio, ranked #5.

Cable Car Capital first reported a position in FBRX in Q4 2023 and has held it in 10 quarters since. The position peaked at $10.9M in Q4 2025. 68 funds tracked by Wall St. Rank hold FBRX as of Q1 2026.

Cable Car Capital held 400,000 shares of Forte Biosciences worth $10.4M as of Q1 2026.
Cable Car Capital left its Forte Biosciences share count unchanged in Q1 2026.
Forte Biosciences made up 3.58% of Cable Car Capital's portfolio in Q1 2026, its #5 holding.
Cable Car Capital first reported a position in Forte Biosciences in Q4 2023 and has held it in 10 quarters since.
Cable Car Capital's Forte Biosciences position peaked at $10.9M in Q4 2025.
68 funds tracked by Wall St. Rank held Forte Biosciences as of Q1 2026.

Based on Cable Car Capital's 13F filing for Q1 2026, filed 15 May 2026.